- All sections
- G - Physics
- G01N - Investigating or analysing materials by determining their chemical or physical properties
- G01N 30/50 - Conditioning of the sorbent material or stationary liquid
Patent holdings for IPC class G01N 30/50
Total number of patents in this class: 116
10-year publication summary
|
5
|
9
|
7
|
8
|
6
|
11
|
6
|
4
|
12
|
6
|
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Shimadzu Corporation | 6370 |
6 |
| Regeneron Pharmaceuticals, Inc. | 4790 |
6 |
| Waters Technologies Corporation | 1799 |
6 |
| GE Healthcare Bio-Sciences AB | 508 |
4 |
| Cytiva Sweden AB | 791 |
4 |
| Bristol-myers Squibb Company | 4764 |
3 |
| JSR Corporation | 2551 |
3 |
| Bio-Rad Laboratories, Inc. | 1612 |
3 |
| Quest Diagnostics Investments LLC | 430 |
3 |
| Repligen Corporation | 299 |
3 |
| Biotage AB | 96 |
2 |
| Genzyme Corporation | 1383 |
2 |
| Global Life Sciences Solutions USA LLC | 529 |
2 |
| Cytiva BioProcess R&D AB | 325 |
2 |
| Nanjing Genscript Biotech Co., Ltd. | 272 |
2 |
| F. Hoffmann-La Roche AG | 7800 |
1 |
| Hoffmann-La Roche Inc. | 3825 |
1 |
| Genentech, Inc. | 4119 |
1 |
| ExxonMobil Research And Engineering Company | 2398 |
1 |
| EMD Millipore Corporation | 633 |
1 |
| Other owners | 60 |